Get RevOps roles in your inbox
We'll email you when new ones are posted
Capricor Therapeutics (NASDAQ: CAPR) is a biotechnology company dedicated to advancing transformative cell and exosome-based therapies for rare diseases. At the forefront of our innovation is Deramiocel (CAP-1002), our lead cell therapy in late-stage development for Duchenne muscular dystrophy. We are also harnessing our proprietary StealthX™ exosome platform to unlock new possibilities in targeted delivery and vaccinology. Every program reflects our commitment to pushing the boundaries of science and delivering life-changing treatments to patients and families who need them most.
This role will serve as the executive leader responsible for building and running the commercial infrastructure that powers Capricor's first launch, Deramiocel, our lead cell therapy for Duchenne muscular dystrophy. This role will design the end-to-end operational backbone that enables a high-performing field organization, disciplined commercial decision-making, and scalable systems across a complex rare disease and advanced-therapy landscape.
The ideal candidate brings deep commercial operations expertise, proven leadership launching rare disease or specialty therapies, and a hands-on builder mindset suited for a fast-growing biotech at a pivotal stage of commercialization.
Set the vision and roadmap for Commercial Operations in support of Deramiocel's launch, spanning sales operations, analytics, forecasting, incentive compensation, territory design, CRM, and commercial systems.
Build and lead a high-performing Commercial Operations team and operating model tailored to a lean, launch-stage rare disease organization.
Stand up the CRM ecosystem (Veeva or Salesforce), including configuration, targeting, call planning, sample management, and field reporting.
Architect the commercial data environment — data warehouse and aggregator strategy (Databricks, Snowflake), dashboarding (Tableau, Power BI), and integration of claims, specialty pharmacy, HUB, patient services, and distribution data.
Lead forecasting, demand planning, quota setting, territory alignment, and incentive compensation design and administration.
Establish data governance, master data management, and data quality standards across the commercial organization.
Partner with Market Access, Marketing, Medical Affairs, Finance, IT, Legal, and Compliance to align commercial operations with enterprise goals and ensure compliant execution.
Own field force enablement — targeting, segmentation, call planning, field effectiveness analytics, and the operational elements of commercial training.
Design KPI and reporting frameworks that give the Commercial Leadership Team and executive team real-time visibility into launch performance.
Select, contract, and manage commercial operations vendors and service providers, including QBR ownership, SLA oversight, and budget accountability.
Perform other duties as may be assigned from time to time.
Education: Bachelor's degree required; MBA or other advanced degree strongly preferred.
Experience: 12+ years in biopharmaceutical commercial operations, including 5+ years in a leadership role and direct experience launching rare disease, advanced therapy, or specialty products.
Deep Expertise: Sales operations, forecasting, incentive compensation, territory alignment, CRM deployment, and commercial data strategy (claims, specialty pharmacy, HUB, distribution).
Executive Leadership: Demonstrated success building commercial infrastructure from the ground up, leading cross-functional initiatives, and managing strategic vendor relationships.
Strategic Acumen: Ability to translate commercial strategy into durable systems, processes, and analytics that drive field performance and disciplined decision-making.
Professional office or remote environment, with occasional travel for cross‑functional planning meetings and vendor engagements.
Ability to manage multiple priorities in a dynamic, rapidly evolving launch environment.
Extended periods of computer-based work, including video conferencing and collaborative software platforms.
Domestic travel as needed (approximately 10 to 15%) for team meetings, vendor engagements, and industry conferences.
RevOps Roles analysis
Benefits, tools, and company context we extract from the full posting and classify, so you can scan in seconds what the write-up buries in prose.
Opens in a new tab
Capricor Therapeutics is a clinical-stage biotechnology company developing cell and exosome-based therapies for treating rare diseases. Its lead candidate, deramiocel, targets Duchenne muscular dystrophy, and the company also develops exosome-based vaccines and therapeutics.
Visit website